Diabetes is one of the most common chronic diseases and is estimated to affect more than 32 million European Union (EU) citizens, which is nearly 10% of the total EU population. An additional 32 million EU citizens are not yet diagnosed or have pre-diabetes, and rates of diabetes are expected to further rise as the population ages. Annual costs of diabetes in 2010 were approximately €300 billion, and the European Parliament now considers diabetes an epidemic. Horizon 2020, the upcoming European Commission Research Framework Programme, will dictate how much funding is available for scientific research in Europe. EURADIA, the Alliance for European Diabetes Research, is working to ensure that Horizon 2020 will allocate sufficient funding to health research in light of the increasing economic consequences of chronic diseases such as diabetes.